| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 28 | 2024 | 1112 | 3.440 |
Why?
|
| Heart Defects, Congenital | 28 | 2022 | 1814 | 2.630 |
Why?
|
| Heart Transplantation | 20 | 2022 | 853 | 2.340 |
Why?
|
| Pulmonary Artery | 11 | 2022 | 440 | 2.290 |
Why?
|
| Extracorporeal Membrane Oxygenation | 26 | 2016 | 628 | 2.210 |
Why?
|
| Truncus Arteriosus, Persistent | 4 | 2021 | 17 | 2.200 |
Why?
|
| Reoperation | 15 | 2021 | 828 | 2.010 |
Why?
|
| Postoperative Complications | 14 | 2024 | 3056 | 1.550 |
Why?
|
| Heart-Assist Devices | 20 | 2022 | 1035 | 1.470 |
Why?
|
| Infant | 68 | 2024 | 12437 | 1.460 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2020 | 278 | 1.310 |
Why?
|
| Aortic Coarctation | 3 | 2021 | 108 | 1.230 |
Why?
|
| Aorta, Thoracic | 6 | 2021 | 527 | 1.140 |
Why?
|
| Retrospective Studies | 66 | 2024 | 16239 | 1.120 |
Why?
|
| Heart Valve Prosthesis | 4 | 2020 | 301 | 1.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2020 | 436 | 1.100 |
Why?
|
| Norwood Procedures | 6 | 2020 | 101 | 1.080 |
Why?
|
| Infant, Newborn | 45 | 2024 | 8170 | 1.050 |
Why?
|
| Aortic Stenosis, Supravalvular | 2 | 2020 | 19 | 1.050 |
Why?
|
| Scimitar Syndrome | 3 | 2021 | 52 | 1.020 |
Why?
|
| Treatment Outcome | 48 | 2024 | 12262 | 0.980 |
Why?
|
| Bioprosthesis | 3 | 2015 | 113 | 0.980 |
Why?
|
| Child, Preschool | 54 | 2024 | 13978 | 0.940 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2015 | 85 | 0.930 |
Why?
|
| Aortopulmonary Septal Defect | 1 | 2024 | 4 | 0.910 |
Why?
|
| Truncus Arteriosus | 2 | 2021 | 13 | 0.900 |
Why?
|
| Heart Septal Defects | 2 | 2022 | 37 | 0.840 |
Why?
|
| Vascular Surgical Procedures | 4 | 2021 | 575 | 0.820 |
Why?
|
| Follow-Up Studies | 23 | 2024 | 5126 | 0.800 |
Why?
|
| Child | 55 | 2024 | 24327 | 0.790 |
Why?
|
| Hypoplastic Left Heart Syndrome | 8 | 2020 | 252 | 0.770 |
Why?
|
| Heart Ventricles | 7 | 2021 | 764 | 0.770 |
Why?
|
| Heart Valves | 2 | 2020 | 50 | 0.760 |
Why?
|
| Airway Extubation | 3 | 2018 | 67 | 0.750 |
Why?
|
| Humans | 111 | 2024 | 124005 | 0.740 |
Why?
|
| Postoperative Care | 5 | 2018 | 294 | 0.730 |
Why?
|
| Male | 79 | 2024 | 60908 | 0.720 |
Why?
|
| Vena Cava, Inferior | 2 | 2013 | 103 | 0.680 |
Why?
|
| Heart Valve Diseases | 2 | 2020 | 169 | 0.680 |
Why?
|
| Survival Rate | 12 | 2020 | 2035 | 0.650 |
Why?
|
| Coronary Vessels | 2 | 2020 | 537 | 0.650 |
Why?
|
| Cardiopulmonary Bypass | 10 | 2020 | 349 | 0.650 |
Why?
|
| Female | 74 | 2024 | 66186 | 0.640 |
Why?
|
| Aneurysm | 2 | 2012 | 91 | 0.640 |
Why?
|
| Abnormalities, Multiple | 3 | 2012 | 959 | 0.640 |
Why?
|
| Mitral Valve | 2 | 2020 | 248 | 0.630 |
Why?
|
| Aortic Diseases | 1 | 2021 | 197 | 0.630 |
Why?
|
| Tetralogy of Fallot | 5 | 2021 | 162 | 0.630 |
Why?
|
| Prostheses and Implants | 2 | 2022 | 150 | 0.630 |
Why?
|
| Heart Failure | 13 | 2022 | 2287 | 0.620 |
Why?
|
| Time Factors | 22 | 2024 | 6278 | 0.620 |
Why?
|
| Arkansas | 10 | 2015 | 58 | 0.580 |
Why?
|
| Intraoperative Complications | 3 | 2017 | 173 | 0.580 |
Why?
|
| Pulmonary Valve Insufficiency | 2 | 2015 | 41 | 0.570 |
Why?
|
| Surgical Sponges | 1 | 2017 | 1 | 0.570 |
Why?
|
| Kaolin | 1 | 2017 | 2 | 0.570 |
Why?
|
| Phrenic Nerve | 1 | 2017 | 11 | 0.560 |
Why?
|
| Hemostatic Techniques | 1 | 2017 | 32 | 0.560 |
Why?
|
| Magnets | 1 | 2017 | 22 | 0.550 |
Why?
|
| Hemodynamics | 5 | 2018 | 850 | 0.550 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2017 | 37 | 0.550 |
Why?
|
| Pulmonary Valve | 2 | 2015 | 92 | 0.530 |
Why?
|
| Thrombosis | 1 | 2021 | 518 | 0.530 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 154 | 0.520 |
Why?
|
| Double Outlet Right Ventricle | 2 | 2015 | 21 | 0.510 |
Why?
|
| Fontan Procedure | 5 | 2010 | 183 | 0.490 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 293 | 0.480 |
Why?
|
| Subclavian Artery | 2 | 2012 | 74 | 0.470 |
Why?
|
| Polytetrafluoroethylene | 1 | 2015 | 84 | 0.470 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 365 | 0.470 |
Why?
|
| Adolescent | 31 | 2022 | 19222 | 0.470 |
Why?
|
| Vascular Malformations | 2 | 2012 | 87 | 0.450 |
Why?
|
| Forecasting | 1 | 2015 | 350 | 0.440 |
Why?
|
| Transportation of Patients | 2 | 2011 | 58 | 0.440 |
Why?
|
| Heart Diseases | 5 | 2013 | 489 | 0.440 |
Why?
|
| Pulmonary Veins | 3 | 2024 | 161 | 0.440 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2011 | 118 | 0.430 |
Why?
|
| Coronary Circulation | 7 | 2019 | 212 | 0.430 |
Why?
|
| Prosthesis Design | 5 | 2020 | 682 | 0.420 |
Why?
|
| Patient Transfer | 2 | 2011 | 104 | 0.420 |
Why?
|
| Aorta | 3 | 2021 | 535 | 0.400 |
Why?
|
| Shock, Septic | 2 | 2011 | 146 | 0.400 |
Why?
|
| Aortic Arch Syndromes | 1 | 2012 | 11 | 0.390 |
Why?
|
| Heart Rupture | 1 | 2011 | 3 | 0.380 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2012 | 53 | 0.380 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2011 | 13 | 0.380 |
Why?
|
| Atrial Septum | 1 | 2011 | 10 | 0.380 |
Why?
|
| Amiodarone | 1 | 2011 | 45 | 0.370 |
Why?
|
| Equipment Design | 6 | 2017 | 586 | 0.370 |
Why?
|
| Replantation | 2 | 2022 | 56 | 0.360 |
Why?
|
| Deglutition Disorders | 1 | 2012 | 130 | 0.340 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2011 | 222 | 0.340 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2020 | 142 | 0.300 |
Why?
|
| Young Adult | 11 | 2022 | 8971 | 0.290 |
Why?
|
| Age Factors | 8 | 2021 | 2805 | 0.290 |
Why?
|
| Respiration, Artificial | 5 | 2015 | 461 | 0.290 |
Why?
|
| Palliative Care | 5 | 2020 | 427 | 0.280 |
Why?
|
| Vena Cava, Superior | 1 | 2007 | 56 | 0.280 |
Why?
|
| Ebstein Anomaly | 1 | 2007 | 27 | 0.270 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2012 | 808 | 0.270 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2020 | 50 | 0.260 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2007 | 63 | 0.260 |
Why?
|
| Cohort Studies | 13 | 2018 | 4768 | 0.260 |
Why?
|
| Risk Factors | 15 | 2020 | 10239 | 0.260 |
Why?
|
| Foreign Bodies | 1 | 2007 | 104 | 0.260 |
Why?
|
| Respiratory Insufficiency | 3 | 2013 | 231 | 0.250 |
Why?
|
| Hospital Mortality | 10 | 2020 | 1019 | 0.240 |
Why?
|
| Ultrasonography | 5 | 2015 | 931 | 0.240 |
Why?
|
| Thoracic Surgery | 1 | 2007 | 158 | 0.240 |
Why?
|
| Biliary Atresia | 1 | 2007 | 190 | 0.230 |
Why?
|
| Proportional Hazards Models | 4 | 2016 | 1349 | 0.230 |
Why?
|
| Risk Assessment | 9 | 2015 | 3426 | 0.230 |
Why?
|
| Heart Arrest | 3 | 2014 | 351 | 0.220 |
Why?
|
| Prosthesis Implantation | 1 | 2005 | 143 | 0.220 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2024 | 19 | 0.220 |
Why?
|
| Incidence | 6 | 2018 | 3134 | 0.220 |
Why?
|
| Device Removal | 2 | 2022 | 222 | 0.210 |
Why?
|
| Infant, Premature | 1 | 2008 | 813 | 0.210 |
Why?
|
| Azygos Vein | 2 | 2013 | 8 | 0.210 |
Why?
|
| Angioplasty, Balloon | 1 | 2024 | 168 | 0.200 |
Why?
|
| Cause of Death | 3 | 2014 | 472 | 0.200 |
Why?
|
| Pulmonary Atresia | 3 | 2019 | 46 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2012 | 103 | 0.200 |
Why?
|
| Prosthesis Failure | 2 | 2015 | 159 | 0.190 |
Why?
|
| Anastomosis, Surgical | 1 | 2022 | 168 | 0.190 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 1031 | 0.190 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2013 | 213 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2012 | 240 | 0.190 |
Why?
|
| Cardiotonic Agents | 2 | 2018 | 138 | 0.190 |
Why?
|
| Norepinephrine | 3 | 2007 | 175 | 0.180 |
Why?
|
| Factor VIIa | 1 | 2020 | 24 | 0.180 |
Why?
|
| Arterial Switch Operation | 1 | 2020 | 22 | 0.170 |
Why?
|
| Tracheal Stenosis | 1 | 2020 | 31 | 0.170 |
Why?
|
| Brain Infarction | 1 | 2020 | 30 | 0.170 |
Why?
|
| Myxoma | 1 | 2020 | 29 | 0.170 |
Why?
|
| Heart | 4 | 2006 | 708 | 0.170 |
Why?
|
| Coronary Stenosis | 1 | 2021 | 72 | 0.170 |
Why?
|
| Heart Atria | 1 | 2022 | 315 | 0.170 |
Why?
|
| Cattle | 1 | 2021 | 565 | 0.170 |
Why?
|
| Discrete Subaortic Stenosis | 1 | 2019 | 7 | 0.170 |
Why?
|
| Vascular Ring | 1 | 2019 | 6 | 0.160 |
Why?
|
| Aortic Valve | 2 | 2020 | 443 | 0.160 |
Why?
|
| HLA Antigens | 2 | 2013 | 243 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 101 | 0.160 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 27 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2004 | 370 | 0.160 |
Why?
|
| Chromosome Deletion | 2 | 2012 | 645 | 0.160 |
Why?
|
| Cyanosis | 2 | 2012 | 42 | 0.160 |
Why?
|
| Echocardiography | 6 | 2020 | 1048 | 0.160 |
Why?
|
| Actuarial Analysis | 2 | 2016 | 34 | 0.150 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2015 | 158 | 0.150 |
Why?
|
| Drug Dosage Calculations | 1 | 2018 | 19 | 0.150 |
Why?
|
| Stents | 1 | 2024 | 877 | 0.140 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 211 | 0.140 |
Why?
|
| Hospitals, Pediatric | 4 | 2012 | 772 | 0.140 |
Why?
|
| Waiting Lists | 2 | 2016 | 227 | 0.140 |
Why?
|
| Cardiology | 2 | 2021 | 503 | 0.140 |
Why?
|
| Blood Substitutes | 2 | 2007 | 6 | 0.140 |
Why?
|
| Ventricular Fibrillation | 2 | 2007 | 51 | 0.140 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 265 | 0.130 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 336 | 0.130 |
Why?
|
| Databases, Factual | 3 | 2016 | 1172 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 373 | 0.130 |
Why?
|
| Hemodilution | 2 | 2006 | 15 | 0.130 |
Why?
|
| Pulmonary Circulation | 2 | 2008 | 121 | 0.130 |
Why?
|
| North America | 3 | 2011 | 239 | 0.130 |
Why?
|
| Gastrostomy | 3 | 2011 | 84 | 0.120 |
Why?
|
| Texas | 2 | 2020 | 3580 | 0.120 |
Why?
|
| Odds Ratio | 3 | 2018 | 1252 | 0.120 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 47 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 874 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 293 | 0.120 |
Why?
|
| Recurrence | 2 | 2016 | 1421 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2012 | 460 | 0.110 |
Why?
|
| Adult | 11 | 2022 | 29292 | 0.110 |
Why?
|
| Respiratory Tract Fistula | 1 | 2013 | 15 | 0.110 |
Why?
|
| Length of Stay | 7 | 2018 | 1300 | 0.110 |
Why?
|
| Bronchial Fistula | 1 | 2013 | 22 | 0.110 |
Why?
|
| Pleural Diseases | 1 | 2013 | 27 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 84 | 0.110 |
Why?
|
| Cardiac Output, Low | 1 | 2013 | 67 | 0.110 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2015 | 174 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 585 | 0.110 |
Why?
|
| Atrial Appendage | 1 | 2013 | 46 | 0.110 |
Why?
|
| Isoantibodies | 1 | 2013 | 71 | 0.100 |
Why?
|
| Ventilator Weaning | 1 | 2013 | 23 | 0.100 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2012 | 133 | 0.100 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 41 | 0.100 |
Why?
|
| Heart Septum | 1 | 2012 | 54 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 317 | 0.100 |
Why?
|
| Positive-Pressure Respiration | 1 | 2013 | 82 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2013 | 313 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2012 | 314 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1421 | 0.100 |
Why?
|
| Coronary Artery Bypass | 1 | 2016 | 509 | 0.100 |
Why?
|
| Coronary Angiography | 2 | 2019 | 425 | 0.100 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2012 | 3 | 0.100 |
Why?
|
| Radiography | 2 | 2011 | 823 | 0.100 |
Why?
|
| Preoperative Care | 2 | 2011 | 354 | 0.100 |
Why?
|
| Diverticulum | 1 | 2012 | 28 | 0.100 |
Why?
|
| Heart Block | 1 | 2012 | 40 | 0.100 |
Why?
|
| Ventricular Function | 1 | 2012 | 91 | 0.100 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2011 | 31 | 0.100 |
Why?
|
| DiGeorge Syndrome | 1 | 2012 | 79 | 0.090 |
Why?
|
| Career Choice | 1 | 2013 | 144 | 0.090 |
Why?
|
| Pediatrics | 1 | 2021 | 1157 | 0.090 |
Why?
|
| Aortography | 1 | 2012 | 199 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 1879 | 0.090 |
Why?
|
| Hepacivirus | 1 | 2013 | 241 | 0.090 |
Why?
|
| Hemolysis | 1 | 2011 | 111 | 0.090 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2011 | 113 | 0.090 |
Why?
|
| Ambulances | 1 | 2011 | 23 | 0.090 |
Why?
|
| Air Ambulances | 1 | 2011 | 26 | 0.090 |
Why?
|
| Equipment Safety | 1 | 2011 | 36 | 0.090 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2010 | 8 | 0.090 |
Why?
|
| Assisted Circulation | 1 | 2011 | 36 | 0.090 |
Why?
|
| Germany | 1 | 2011 | 65 | 0.090 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2011 | 115 | 0.090 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2011 | 40 | 0.090 |
Why?
|
| Myocardial Reperfusion | 2 | 2007 | 72 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 157 | 0.090 |
Why?
|
| Hemoglobins | 2 | 2011 | 303 | 0.090 |
Why?
|
| Brain | 2 | 2020 | 2977 | 0.090 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 28 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 427 | 0.090 |
Why?
|
| Heart Arrest, Induced | 1 | 2010 | 75 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2011 | 196 | 0.080 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 202 | 0.080 |
Why?
|
| Heparin | 2 | 2008 | 228 | 0.080 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 207 | 0.080 |
Why?
|
| Lactates | 1 | 2010 | 93 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 280 | 0.080 |
Why?
|
| Catheterization | 2 | 2011 | 236 | 0.080 |
Why?
|
| Myocarditis | 1 | 2011 | 130 | 0.080 |
Why?
|
| Expectorants | 1 | 2009 | 7 | 0.080 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 2137 | 0.080 |
Why?
|
| Deoxyribonucleases | 1 | 2009 | 27 | 0.080 |
Why?
|
| Middle Aged | 5 | 2017 | 26569 | 0.080 |
Why?
|
| Pulmonary Atelectasis | 1 | 2009 | 14 | 0.080 |
Why?
|
| Lymphopenia | 1 | 2009 | 36 | 0.080 |
Why?
|
| Syndrome | 2 | 2013 | 1116 | 0.080 |
Why?
|
| Logistic Models | 2 | 2011 | 1799 | 0.080 |
Why?
|
| Cineangiography | 1 | 2008 | 17 | 0.080 |
Why?
|
| Survival Analysis | 4 | 2016 | 1490 | 0.080 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2013 | 445 | 0.080 |
Why?
|
| Pipecolic Acids | 1 | 2008 | 7 | 0.080 |
Why?
|
| Hepatitis C, Chronic | 1 | 2013 | 324 | 0.080 |
Why?
|
| Stroke | 2 | 2013 | 973 | 0.080 |
Why?
|
| Ketamine | 1 | 2012 | 215 | 0.080 |
Why?
|
| Clinical Protocols | 1 | 2009 | 236 | 0.070 |
Why?
|
| Cerebral Hemorrhage | 1 | 2009 | 143 | 0.070 |
Why?
|
| Vascular Resistance | 1 | 2008 | 186 | 0.070 |
Why?
|
| Risk | 2 | 2013 | 754 | 0.070 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2007 | 43 | 0.070 |
Why?
|
| Catheters | 2 | 2022 | 87 | 0.070 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 93 | 0.070 |
Why?
|
| Critical Care | 2 | 2012 | 654 | 0.070 |
Why?
|
| Histocompatibility Testing | 1 | 2007 | 148 | 0.070 |
Why?
|
| Feeding Methods | 1 | 2007 | 37 | 0.070 |
Why?
|
| Animals | 8 | 2021 | 33994 | 0.070 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2007 | 70 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2011 | 487 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 2086 | 0.070 |
Why?
|
| Compartment Syndromes | 1 | 2007 | 31 | 0.070 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2006 | 5 | 0.070 |
Why?
|
| Receptor, Endothelin A | 1 | 2006 | 12 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2008 | 588 | 0.070 |
Why?
|
| Cholesterol | 1 | 2009 | 535 | 0.070 |
Why?
|
| Hemofiltration | 1 | 2006 | 14 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 222 | 0.070 |
Why?
|
| Kidney | 1 | 2013 | 1352 | 0.070 |
Why?
|
| Body Weight | 1 | 2010 | 996 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2009 | 388 | 0.070 |
Why?
|
| Abdomen | 1 | 2007 | 127 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 237 | 0.060 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2007 | 146 | 0.060 |
Why?
|
| Vocal Cord Paralysis | 1 | 2007 | 68 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2012 | 764 | 0.060 |
Why?
|
| Shock, Cardiogenic | 2 | 2022 | 193 | 0.060 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2006 | 87 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 875 | 0.060 |
Why?
|
| Guinea Pigs | 4 | 2007 | 166 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 3543 | 0.060 |
Why?
|
| Atrial Flutter | 1 | 2005 | 32 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2009 | 540 | 0.060 |
Why?
|
| Sympathetic Nervous System | 1 | 2005 | 63 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2005 | 72 | 0.060 |
Why?
|
| Organ Preservation | 1 | 2005 | 45 | 0.060 |
Why?
|
| Allied Health Personnel | 1 | 2006 | 74 | 0.060 |
Why?
|
| Fluorocarbons | 1 | 2005 | 56 | 0.060 |
Why?
|
| Inflammation | 1 | 2012 | 1421 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2005 | 78 | 0.060 |
Why?
|
| Decision Making | 1 | 2010 | 653 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2021 | 440 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2011 | 777 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2011 | 846 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 1084 | 0.050 |
Why?
|
| Angiography | 1 | 2024 | 216 | 0.050 |
Why?
|
| Chordae Tendineae | 1 | 2003 | 7 | 0.050 |
Why?
|
| Emergencies | 1 | 2004 | 172 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 276 | 0.050 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 1 | 2002 | 2 | 0.050 |
Why?
|
| Hypoxia | 1 | 2004 | 249 | 0.050 |
Why?
|
| Hypothermia, Induced | 2 | 2020 | 165 | 0.050 |
Why?
|
| Aged | 3 | 2017 | 19516 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2020 | 1369 | 0.050 |
Why?
|
| Critical Illness | 3 | 2012 | 601 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2013 | 1177 | 0.050 |
Why?
|
| Postoperative Period | 2 | 2014 | 328 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 709 | 0.050 |
Why?
|
| Heart Aneurysm | 1 | 2002 | 39 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 1389 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 3146 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2013 | 338 | 0.050 |
Why?
|
| Aneurysm, False | 1 | 2002 | 105 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 427 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 2879 | 0.040 |
Why?
|
| Facial Paralysis | 1 | 2020 | 35 | 0.040 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 27 | 0.040 |
Why?
|
| Sepsis | 1 | 2004 | 467 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2007 | 968 | 0.040 |
Why?
|
| Hemorrhage | 2 | 2014 | 467 | 0.040 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2012 | 135 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 210 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 338 | 0.040 |
Why?
|
| Biomarkers | 3 | 2015 | 3046 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 723 | 0.040 |
Why?
|
| Trachea | 1 | 2020 | 203 | 0.040 |
Why?
|
| Thoracotomy | 1 | 2019 | 108 | 0.040 |
Why?
|
| Nordefrin | 1 | 2018 | 2 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2014 | 489 | 0.040 |
Why?
|
| Peritoneal Dialysis | 2 | 2012 | 117 | 0.040 |
Why?
|
| Milrinone | 1 | 2018 | 30 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 635 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2010 | 442 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 95 | 0.040 |
Why?
|
| Markov Chains | 1 | 2018 | 84 | 0.040 |
Why?
|
| Warfarin | 2 | 2008 | 119 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 632 | 0.030 |
Why?
|
| Graft Rejection | 2 | 2013 | 588 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2012 | 479 | 0.030 |
Why?
|
| Epinephrine | 1 | 2018 | 179 | 0.030 |
Why?
|
| Comorbidity | 2 | 2013 | 1527 | 0.030 |
Why?
|
| United States | 3 | 2020 | 10853 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2018 | 282 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 2009 | 48 | 0.030 |
Why?
|
| Perfusion | 2 | 2009 | 201 | 0.030 |
Why?
|
| Gestational Age | 1 | 2020 | 1160 | 0.030 |
Why?
|
| Dopamine | 1 | 2018 | 285 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2010 | 1007 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 263 | 0.030 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 745 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 864 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 645 | 0.030 |
Why?
|
| Dogs | 2 | 2006 | 768 | 0.030 |
Why?
|
| Random Allocation | 2 | 2005 | 435 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2015 | 153 | 0.030 |
Why?
|
| Prognosis | 2 | 2014 | 4605 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2014 | 43 | 0.030 |
Why?
|
| Sternotomy | 1 | 2014 | 41 | 0.030 |
Why?
|
| Berlin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Autopsy | 1 | 2014 | 111 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 2037 | 0.030 |
Why?
|
| Compassionate Use Trials | 1 | 2013 | 14 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 1476 | 0.030 |
Why?
|
| Thoracic Injuries | 1 | 2013 | 91 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 103 | 0.030 |
Why?
|
| Hyperbilirubinemia | 1 | 2013 | 41 | 0.030 |
Why?
|
| Body Size | 1 | 2013 | 55 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 78 | 0.030 |
Why?
|
| Cardiac Catheterization | 2 | 2010 | 631 | 0.030 |
Why?
|
| Shock | 1 | 2013 | 90 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 64 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 253 | 0.020 |
Why?
|
| Centrifugation | 1 | 2011 | 25 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2013 | 141 | 0.020 |
Why?
|
| Mortality | 1 | 2013 | 237 | 0.020 |
Why?
|
| Heart Rate | 2 | 2005 | 583 | 0.020 |
Why?
|
| Body Surface Area | 1 | 2011 | 31 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 2010 | 35 | 0.020 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 2010 | 3 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 83 | 0.020 |
Why?
|
| Fundoplication | 1 | 2011 | 65 | 0.020 |
Why?
|
| Ductus Arteriosus | 1 | 2011 | 62 | 0.020 |
Why?
|
| Myocardium | 2 | 2006 | 996 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2011 | 154 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2012 | 251 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2010 | 75 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 668 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2013 | 196 | 0.020 |
Why?
|
| Laparotomy | 1 | 2011 | 135 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 300 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 1223 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6113 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 412 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2010 | 217 | 0.020 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2009 | 20 | 0.020 |
Why?
|
| Phenoxybenzamine | 1 | 2009 | 12 | 0.020 |
Why?
|
| Bacteremia | 1 | 2013 | 403 | 0.020 |
Why?
|
| Child Development | 1 | 2012 | 266 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2009 | 29 | 0.020 |
Why?
|
| Sternum | 1 | 2009 | 54 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 2009 | 28 | 0.020 |
Why?
|
| Nutritional Support | 1 | 2009 | 54 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2009 | 169 | 0.020 |
Why?
|
| Home Care Services | 1 | 2009 | 67 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2013 | 365 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 155 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 2010 | 117 | 0.020 |
Why?
|
| Child Nutrition Disorders | 1 | 2009 | 75 | 0.020 |
Why?
|
| Heparin Antagonists | 1 | 2008 | 5 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2009 | 153 | 0.020 |
Why?
|
| Protamines | 1 | 2008 | 13 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 471 | 0.020 |
Why?
|
| Dipyridamole | 1 | 2008 | 29 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2013 | 480 | 0.020 |
Why?
|
| Antithrombin III | 1 | 2008 | 25 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2008 | 23 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2008 | 42 | 0.020 |
Why?
|
| Program Development | 1 | 2009 | 186 | 0.020 |
Why?
|
| Weight Gain | 1 | 2011 | 404 | 0.020 |
Why?
|
| Thrombin | 1 | 2008 | 59 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1629 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 746 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2441 | 0.020 |
Why?
|
| Energy Intake | 1 | 2010 | 493 | 0.020 |
Why?
|
| Drainage | 1 | 2009 | 256 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 254 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 567 | 0.020 |
Why?
|
| Swine | 1 | 2011 | 1177 | 0.020 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2007 | 52 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3264 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2008 | 547 | 0.020 |
Why?
|
| Liposomes | 1 | 2007 | 174 | 0.020 |
Why?
|
| Aspirin | 1 | 2008 | 224 | 0.020 |
Why?
|
| Endothelin A Receptor Antagonists | 1 | 2006 | 9 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 376 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2006 | 41 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2008 | 263 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 1010 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 1285 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 262 | 0.020 |
Why?
|
| Arginine | 1 | 2008 | 331 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 492 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2011 | 491 | 0.020 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2005 | 7 | 0.020 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2005 | 12 | 0.020 |
Why?
|
| Tromethamine | 1 | 2005 | 9 | 0.020 |
Why?
|
| Bradykinin | 1 | 2005 | 59 | 0.020 |
Why?
|
| Reperfusion | 1 | 2005 | 25 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2005 | 16 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2005 | 55 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2007 | 151 | 0.020 |
Why?
|
| Denervation | 1 | 2005 | 29 | 0.020 |
Why?
|
| Emulsions | 1 | 2005 | 69 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 149 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 1178 | 0.020 |
Why?
|
| Histamine | 1 | 2005 | 44 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2005 | 59 | 0.020 |
Why?
|
| Graft Survival | 1 | 2007 | 532 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 256 | 0.020 |
Why?
|
| Hemorheology | 1 | 2004 | 25 | 0.010 |
Why?
|
| Tracheostomy | 1 | 2007 | 192 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 322 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2005 | 161 | 0.010 |
Why?
|
| Water | 1 | 2005 | 183 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 304 | 0.010 |
Why?
|
| Systole | 1 | 2004 | 198 | 0.010 |
Why?
|
| Diastole | 1 | 2004 | 170 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 205 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 711 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2862 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 434 | 0.010 |
Why?
|
| Yohimbine | 1 | 2002 | 18 | 0.010 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2002 | 8 | 0.010 |
Why?
|
| Tricuspid Atresia | 1 | 2002 | 13 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2002 | 40 | 0.010 |
Why?
|
| Symporters | 1 | 2002 | 69 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 579 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2003 | 202 | 0.010 |
Why?
|
| Glucose | 1 | 2005 | 878 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2005 | 972 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2002 | 506 | 0.010 |
Why?
|
| Synapses | 1 | 2002 | 457 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 4333 | 0.010 |
Why?
|